Preveta
PrivateLast Round
Series A
Extension
Nov 14, 2025
Total Funding Raised
$10.72M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Preveta is a healthtech company that provides an AI-powered care navigation platform designed to ensure cancer patients receive appropriate and timely care.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Healthcare Analytics, Medical AI, EHR & EMR, Patient Engagement
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Preveta Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Preveta Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 14, 2025 | ||||
| Series A | Dec 16, 2022 | ||||
| Seed | Mar 26, 2021 | ||||
| Accelerator | Jul 13, 2020 |
Key People
Founding team and executive leadership
Preveta Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | Accelerator |
| Bullpen Capital | Series A Extension, Series A |
| TSV Capital | Seed |
| MaC Venture Capital | Seed |
| Sovereign's Capital | Series A, Series A Extension |
| TMV | Series A Extension, Series A |
| Navigate Ventures | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors grew 168% MoM, reaching 1.3K.
- Mar 26, 2021
$2M round led by MaC Venture Capital and TSV Capital
Preveta Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Preveta's valuation, stock price, and market status.